Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 6 Advanced Solid Tumours 5 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Uterine Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Hematologic Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Rhabdomyosarcoma 1

Interventions

Paclitaxel 115 Carboplatin 114 Cisplatin 46 Topotecan 43 Gemcitabine 31 Cyclophosphamide 31 Docetaxel 28 Bevacizumab 28 liposomal doxorubicin 27 Filgrastim 20 pembrolizumab 19 Peripheral Blood Stem Cell Transplantation 18 Taxes 15 Drug Therapy 15 Hyperthermic Intraperitoneal Chemotherapy 13 sargramostim 12 olaparib 12 Immunohistochemistry 11 Chemotherapy, Adjuvant 11 Surgical Procedures, Operative 10 Therapeutics 9 Flow Cytometry 9 Etoposide 9 oregovomab 8 niraparib 8 mirvetuximab soravtansine 8 Psychiatric Rehabilitation 8 Nivolumab 8 Amifostine 8 rucaparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × adavosertib × Clear all

NCT01164995 2023-09-07

M10MKO

The Netherlands Cancer Institute

Phase 2 Completed

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡